Impeachement report lays out President Biden’s alleged offenses

“The Biden family, with the help and knowledge of the president, used the Biden family name around the world to rake in nearly $30 million from overseas entities in Ukraine, China, Romania and elsewhere in secretive influence deals.”

President Joe Biden committed impeachable offenses in his role in his family’s alleged overseas business dealings, a newly released report from the U.S. House Ways and Committee alleges.

“As described in this report, the Committees have accumulated evidence demonstrating that President Biden has engaged in impeachable conduct,” the report said.

The 291-page report lays out in detail what have at times been murky allegations against the president.

House Oversight Chair Rep. James Comer, R-Ky., helped spearhead the investigation, uncovering and laying out evidence. He and Republicans on the impeachment committee argue that the Biden family, with the help and knowledge of the president, used the Biden family name around the world to rake in nearly $30 million from overseas entities in Ukraine, China, Romania and elsewhere in secretive influence deals.

“In order to obscure the source of these funds, the Biden family and their associates set up shell companies to conceal these payments from scrutiny,” the report said. “The Biden family used proceeds from these business activities to provide hundreds of thousands of dollars to Joe Biden—including thousands of dollars that are directly traceable to China.”

Biden has brushed off questions about his involvement in a scheme being highlighted in the Republicans’ report. The administration has yet to release a formal response in reaction to the report.

A key question in the investigation has been, even if Hunter Biden and others monetized the “Biden brand,” how much did the president really know or participate?

“Witnesses acknowledged that Hunter Biden involved Vice President Biden in many of his business dealings with Russian, Romanian, Chinese, Kazakhstani, and Ukrainian individuals and companies,” the report said. “Then-Vice President Biden met or spoke with nearly every one of the Biden family’s foreign business associates, including those from Ukraine, China, Russia, and Kazakhstan. As a result, the Biden family has received millions of dollars from these foreign entities.”

The president has repeatedly brushed off these allegations, and so far Republicans have not gotten the needed votes to make impeachment a serious threat.

From the report:

First and foremost, overwhelming evidence demonstrates that President Biden participated in a conspiracy to monetize his office of public trust to enrich his family. Among other aspects of this conspiracy, the Biden family and their business associates received tens of millions of dollars from foreign interests by leading those interests to believe that such payments would provide them access to and influence with President Biden. As Vice President, President Biden actively participated in this conspiracy by, among other things, attending dinners with his family’s foreign business partners and speaking to them by phone, often when being placed on speakerphone by Hunter Biden. For example, in 2014, Vice President Biden attended a dinner for Hunter Biden with Russian oligarch Yelena Baturina.4 Following the dinner, Baturina wired $3.5 million to Rosemont Seneca Thornton, a firm associated with Hunter Biden. Then, months later, as Hunter Biden and his business associates continued to solicit more money from Baturina, Vice President Biden participated in a phone call with Baturina and Hunter Biden where Vice President Biden told Baturina, “you be good to my boy.” Moreover, President Biden knowingly participated in this conspiracy. Based on the totality of the evidence, it is inconceivable that President Biden did not understand that he was taking part in an effort to enrich his family by abusing his office of public trust.

“The Biden-Harris Administration has lied to the American people time and again to cover up and obstruct the investigation into tax crimes committed by a Biden family business enterprise that capitalized on political power,” Rep. Jason Smith, R-Mo., who chairs the House Ways and Means Committee, said in a statement. “The American people have been shocked to learn the magnitude of the scheme going back to the President’s time as Vice President, when Biden family members were allowed to use Air Force Two as their own private business jet.

“None of this would have come to light had it not been for the two IRS whistleblowers who were tired of watching their investigation into the President’s son become obstructed, delayed, and denied the ability to move forward as the pursuit of truth demanded,” he added.

The whistleblowers in question are Supervisory Special Agent Gary Shapley and Criminal Investigator Joseph Ziegler, two IRS employees with nearly three decades of combined federal experience.

Those whistleblowers came forward and testified before Congress about Hunter Biden’s alleged tax crimes, saying that this case was unlike any other. One whistleblower testified that the Biden administration interfered in the investigation to protect Hunter and prevent a raid at the president’s Delaware home.

Earlier this year, Hunter, who still faces tax charges Biden was found guilty on federal gun charges.

President Biden has said he will not pardon his son.

Whether Biden falling out of favor with his own party in the presidential election will change that trajectory remains to be seen.

“Americans now know Joe Biden was ‘the brand’ the Bidens sold around the world to enrich the Biden family, and Joe Biden knew of, benefitted from, and participated in his family’s influence peddling schemes,” Comer said in a statement. “The entire Biden influence peddling model relied on Joe Biden’s presence—at meetings, on the phone, or at dinners—to demonstrate his family members’ influence over him, and he repeatedly provided it.”

Casey Harper

D.C. Bureau Reporter

Related Topics:#CaseyHarper #TheCenterSquare JoeBidenImpeachmentReport

Up Next

Federal government’s capital gains tax hike is worse than you think

Don't Miss

RFK Jr’s powerful speech to America explaining his dramatic political journey

Todayville

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Bongino announces FBI will release files on COVID cover up, Mar-a-Lago Raid and more

Health / 8 hours ago

Trump signs executive order aiming to slash prescription drug costs up to 90%

Business / 8 hours ago

The ESG Shell Game Behind The U.S. Plastics Pact

International

Bongino announces FBI will release files on COVID cover up, Mar-a-Lago Raid and more

Published on May 12, 2025

Todayville

MxM News

Quick Hit:

FBI Deputy Director Dan Bongino announced that the bureau will begin releasing information on a number of controversial investigations long shielded from public view.

Key Details:

Bongino said the FBI is clearing information on high-profile cases, including COVID, Crossfire Hurricane, and the Trump Mar-a-Lago raid.
The bureau is actively working with the DOJ on releasing Epstein case details and cracking down on child sexual abuse content.
Bongino dismissed media attacks on FBI Director Kash Patel as “verifiable lies” and accused the press of fabricating stories.

Diving Deeper:

FBI Deputy Director Dan Bongino disclosed on Saturday that the bureau will begin releasing information previously kept under tight wraps, including cases that many Americans believe were swept under the rug for political or institutional protection.

Bongino, a former NYPD officer, Secret Service agent, and outspoken conservative commentator, took to X to announce that his office has already started cooperating with Congress and the public by providing long-requested information. Among the cases he cited: the attempted assassination of Rep. Steve Scalise, the Nashville Christian school shooting, the Crossfire Hurricane probe, and the COVID-19 origins and cover-up.

“This isn’t business as usual anymore,” Bongino wrote. “We’re clearing information to Congress, and the public, as quickly as possible.”

One of the most politically explosive revelations relates to the FBI’s handling of the Mar-a-Lago raid, an unprecedented move to search the home of the sitting president’s top political opponent, President Donald Trump. Bongino’s announcement signals that internal communications and case files may soon be scrutinized by congressional investigators and the public alike.

Bongino also confirmed that the agency is working closely with the DOJ on the Epstein case, noting the overwhelming volume of child sexual abuse material that must be reviewed. He emphasized that protecting children remains a core mission of the FBI under his and Director Kash Patel’s leadership.

“Operation ‘Restoring Justice,’ where we locked up child predators and 764 subjects, in every part of the country, is just the beginning,” he wrote. “Think twice if you’ve targeted children, because you’re next.”

The deputy director didn’t hold back in pushing back against media reports that characterized Patel’s leadership as unserious or performative. “The media continue to entirely fabricate stories,” Bongino wrote, describing reports about Patel skipping briefings and attending sports events as “a verifiable lie.”

He defended Patel’s work ethic, noting that the FBI director routinely works 10–12 hour days and meets with top counter-terror officials and global law enforcement partners.

Health

Trump signs executive order aiming to slash prescription drug costs up to 90%

Published on May 12, 2025

Todayville

From The Center Square

By Morgan Sweeney

“Most powerful executive order on pharmacy pricing and health care ever in the history of our nation.”

President Donald Trump hosted a press conference with Secretary of Health and Human Services Robert F. Kennedy, Jr., and other health administration officials Monday morning formally announcing an executive order aiming to drastically reduce what Americans pay for their prescription drugs up to 90%, according to Trump.

The order seeks to reform how much the U.S. pays for pharmaceutical drugs compared to other countries. On average, Americans pay nearly four times more than other countries for their prescription drugs, effectively subsidizing pharmaceutical companies’ research and development costs for others around the world, according to the administration.

The order was immediately met with skepticism by some critics.

“If Trump is serious about making real change rather than just issuing a press release, he will support legislation I will introduce to ensure we pay no more for prescription drugs than people in other major countries,” Sen. Bernie Sanders, I-Vt., posted on X after the press conference, touting his own legislation and saying Trump’s order will be “thrown out by the courts.”

“If we come together, we can get it passed in a few weeks,” Sanders said.

Food and Drug Administration Commissioner and Johns Hopkins surgical oncologist Marty Makary was one of the officials who spoke at the press conference Monday morning.

“We didn’t take an oath to heal patients and then watch their life get ruined financially with their home, mortgage, retirement going down the drain with Go Fund Me campaigns, raising money from church communities and synagogues and friends they haven’t seen in 20 years to try to raise money – for what?” said Food and Drug Administration Commissioner Marty Makary.

“For a system where Americans have been getting ripped off by 10, 12, 15 times higher prices than we see in other countries?”

Makary and others said the “fundamental problem” with American prescription drug costs is a lack of competition in the global marketplace, with Americans comprising only about 4% of the global population but supplying at least two-thirds of drug companies’ revenue globally.

“The fundamental problem in health care is that we’ve had non-competitive markets,” Makary continued. “We can do little things around the edges, or we can transform those markets into competitive markets, and that’s what this executive order does.”

The order intends to secure the “most-favored-nation” price for pharmaceutical drugs for the U.S., or the lowest price among its economic peer countries, through a series of actions. It instructs the U.S. secretary of commerce and the U.S. trade representative to “ensure” that other countries aren’t engaging in practices that “[force] American patients to pay for a disproportionate amount of global pharmaceutical research and development.” Kennedy is to work in coordination with Centers for Medicare and Medicaid Administrator Mehmet Oz and others to develop most-favored-nation target pricing for pharmaceutical companies. It also directs Kennedy to devise direct-to-consumer purchasing programs for drug companies that abide by the president’s most-favored-nation pricing mandate for the U.S.

Oz called the order the “most powerful executive order on pharmacy pricing and health care ever in the history of our nation.”

If drug companies don’t comply, then the order directs Kennedy to create a rulemaking plan to impose the targeted pricing, or certify to Congress that the U.S. can import the drugs that remain too expensive under certain importation waivers. Certain drugs may even have their FDA approvals revoked by Makary.

Kennedy said some politicians, including Sanders, have been promising to “equalize” what the U.S. and Europe pay for pharmaceutical drugs for years, while knowing they can’t deliver on the promise because of the deep entanglement between the pharmaceutical industry and Congress. And even though he too has been promising to do something about the issue for years, he didn’t think he would see a solution emerge in his lifetime.

“I’m just so grateful to be here today. I never thought this would happen in my lifetime,” Kennedy said. “I have a couple of kids who are Democrats, who are big Bernie Sanders fans. When I told them what was going to happen, they had tears in their eyes, because they thought this was never going to happen in our lifetime.”

Kennedy and the other health administration officials who spoke praised the president for being willing to stand up to the industry and its powerful lobby, which has one to three times as many lobbyists in Washington as there are members of Congress and the Supreme Court, according to Kennedy.

“We finally have a president who’s willing to stand up for the American people,” Kennedy said.